Serological Markers of Selected Sexually Transmitted Infections (HBV, HCV, HIV, and Syphilis) in Patients with Anogenital Warts: A Two-Centre, Five-Year Study

Background

Human papillomavirus-induced disruption of the anogenital mucosal barrier may increase susceptibility to other sexually transmitted infections (STIs), and guidelines recommend STI screening in patients with anogenital warts (AGW). We aimed to determine the seroprevalence of concomitant STIs in patients with AGW over a five-year period and to perform an exploratory assessment of associated demographic factors.